Medicine & Life Sciences
Shiga Toxin 2
85%
Hemolytic-Uremic Syndrome
69%
Daunorubicin
68%
Inflammasomes
64%
Heat-Shock Proteins
56%
Interleukin-1
53%
Endotoxins
53%
Interleukin-1beta
51%
Protein Kinases
49%
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
47%
Anthracyclines
45%
Sorafenib
39%
Apoptosis
32%
Antibodies
29%
estropipate
23%
HeLa Cells
21%
Fibrin
15%
Cytokines
14%
Protein Synthesis Inhibitors
13%
Cell Line
12%
Neoplasms
12%
Chemokines
11%
Granulocyte Colony-Stimulating Factor
10%
Keratinocytes
10%
Shiga-Toxigenic Escherichia coli
10%
Antineoplastic Agents
10%
Macrophages
10%
Passive Immunization
9%
Protein Isoforms
8%
Pharmaceutical Preparations
8%
Blood Urea Nitrogen
8%
Leukopenia
8%
Phosphotransferases
8%
Cell Death
8%
Hemolysis
8%
Interleukin-6
7%
Proteinuria
7%
Acute Kidney Injury
7%
Serum
7%
Creatinine
6%
Neutrophils
6%
Caspase 1
6%
Therapeutics
5%
Inflammation
5%
Drug Therapy
5%
Lymphocytes
5%
Agriculture & Biology
Shiga-like toxin 2
88%
hemolytic uremic syndrome
86%
endotoxins
60%
animal models
47%
antibodies
35%
mice
22%
acute kidney injury
12%
blood serum
12%
therapeutics
12%
proteinuria
10%
leukopenia
10%
chemokines
10%
Shiga toxin-producing Escherichia coli
10%
renal function
9%
urea nitrogen
8%
hemolysis
8%
creatinine
7%
immunization
7%
cytokines
7%
neutrophils
7%
inflammation
7%
lymphocytes
6%
injection
5%